Auransa
PrivateLast Round
VC Round
Jan 3, 2019
Est. Valuation
$70.37M
Total Funding Raised
$16.95M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Auransa operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was a VC Round in January 2019.
Auransa is a biotechnology company that has developed an AI-driven platform to discover and develop precision medicines for cancer.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Auransa Comparables
Compare Auransa with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| VeriSIM Life | 83% | |
| Healx | 82% | |
| Aitia | 81% |
For institutional investors. Book with your work email.
Auransa Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jan 3, 2019 | ||||
| Series A | May 31, 2017 | ||||
| Seed | Dec 22, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Auransa Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lux Capital | Seed, Series A, VC Round |
| AME Cloud Ventures | Seed, Series A, VC Round |
| 11.2 Capital | Seed, Series A, VC Round |
| DCVC (Data Collective) | Seed, Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 399% MoM, from 287 to 1.4K.
- May 31, 2017
$14.1M round led by Lux Capital and DCVC.
For institutional investors. Book with your work email.
Auransa Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Auransa's valuation, stock price, and market status.
Is Auransa a public or private company?
Auransa is a private company.
What is the current stock price of Auransa?
Auransa is a private company, so its shares have no public market price. Caplight tracks Auransa's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Auransa worth (valuation)?
Auransa's valuation is estimated at $70.4M based on funding round data.
Can I buy Auransa stock?
Auransa shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Auransa's last funding round?
Auransa's most recent funding round was VC Round on January 3, 2019.
Who are the main investors in Auransa?
Key investors in Auransa include Lux Capital, AME Cloud Ventures, 11.2 Capital, DCVC (Data Collective).
Will Auransa IPO soon?
No public IPO plans have been announced for Auransa.
How can I track Auransa secondary market activity?
Caplight tracks bids, offers, and trades in Auransa's shares on secondary markets.